Carisma Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Carisma Therapeutics has a total shareholder equity of $26.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $89.6M and $63.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$77.61m |
| Equity | US$26.53m |
| Total liabilities | US$63.02m |
| Total assets | US$89.55m |
Recent financial health updates
We're A Little Worried About Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Rate
Mar 26
Here's Why We're Watching Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Situation
Oct 05We're Hopeful That Carisma Therapeutics (NASDAQ:CARM) Will Use Its Cash Wisely
Jun 15Recent updates
Investors Don't See Light At End Of Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Tunnel And Push Stock Down 26%
Apr 19We're A Little Worried About Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Rate
Mar 26Lacklustre Performance Is Driving Carisma Therapeutics, Inc.'s (NASDAQ:CARM) 26% Price Drop
Jan 21The Market Doesn't Like What It Sees From Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Revenues Yet As Shares Tumble 27%
Dec 07Analyst Forecasts Just Became More Bearish On Carisma Therapeutics, Inc. (NASDAQ:CARM)
Nov 12Here's Why We're Watching Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Situation
Oct 05We're Hopeful That Carisma Therapeutics (NASDAQ:CARM) Will Use Its Cash Wisely
Jun 15Financial Position Analysis
Short Term Liabilities: CARM's short term assets ($80.5M) exceed its short term liabilities ($15.9M).
Long Term Liabilities: CARM's short term assets ($80.5M) exceed its long term liabilities ($47.1M).
Debt to Equity History and Analysis
Debt Level: CARM is debt free.
Reducing Debt: CARM had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CARM has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: CARM has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 63.7% each year.